Literature DB >> 26217962

Incidence of preeclampsia in pregnant Swiss women.

Mette-Triin Purde1, Marc Baumann2, Ute Wiedemann1, Urs E Nydegger1, Lorenz Risch3, Daniel Surbek2, Martin Risch4.   

Abstract

QUESTION UNDER STUDY: The epidemiology of preeclampsia in Switzerland is known only from a retrospective registry study. This analysis aimed to prospectively determine the incidence of preeclampsia in a cohort of pregnant women in Switzerland.
METHODS: Pregnant women presenting at gestational week 11-14 at their obstetrician's office were consecutively included and prospectively followed-up until the end of pregnancy. Ultrasound characteristics, blood pressure measurements, body mass index, and personal history were recorded. Duration of pregnancy, occurrence of preeclampsia, birth weight and Apgar scores were recorded as outcomes.
RESULTS: There were 1,300 pregnancies with follow-up available for analysis. Median age was 30 years (interquartile range [IQR] 27-33), median body mass index (BMI) 23.3 kg/m² (IQR 21.2-26.1), median systolic blood pressure 117 mm Hg (IQR 109-126) and median diastolic blood pressure 70 mm Hg (IQR 64-77). A total of 30 women developed preeclampsia, corresponding to an incidence of 2.31% (95% confidence interval [CI] 1.62%-3.28%). Of the women with preeclampsia, 6.66% (95% CI 2.04%-21.42%) had early-onset preeclampsia, 13.33% (95% CI 5.45%-29.83%) progressed to eclampsia, whereas 10% (95% CI 3.63%-28.75%) developed HELLP syndrome (haemolysis, elevated liver enzymes, low platelet count). Nulliparity and prior history of preeclampsia were more frequently seen in pregnancies with preeclampsia than in pregnancies without preeclampsia. BMI, as well as systolic and diastolic blood pressure were higher in pregnancies subsequently developing preeclampsia.
CONCLUSION: The incidence of preeclampsia in Switzerland is in line with frequencies observed elsewhere in the world. Extrapolation to a national level indicates that about 1,911 (range 1,340-2,713) preeclampsia cases per year can be expected to occur in Switzerland.

Entities:  

Mesh:

Year:  2015        PMID: 26217962     DOI: 10.4414/smw.2015.14175

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  10 in total

Review 1.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 2.  Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world.

Authors:  Ning Zhang; Jing Tan; HaiFeng Yang; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2020-09-25       Impact factor: 5.858

3.  Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.

Authors:  Juan Yang; Michelle Pearl; Gerald N DeLorenze; Roberto Romero; Zhong Dong; Laura Jelliffe-Pawlowski; Robert Currier; Monica Flessel; Martin Kharrazi
Journal:  Am J Obstet Gynecol       Date:  2016-04-09       Impact factor: 8.661

4.  Population-based trends and risk factors of early- and late-onset preeclampsia in Taiwan 2001-2014.

Authors:  Shu-Han You; Po-Jen Cheng; Ting-Ting Chung; Chang-Fu Kuo; Hsien-Ming Wu; Pao-Hsien Chu
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-31       Impact factor: 3.007

5.  sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective.

Authors:  Markus Hodel; Patricia R Blank; Petra Marty; Olav Lapaire
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

6.  Reducing the Risk of Preterm Preeclampsia: Comparison of Two First Trimester Screening and Treatment Strategies in a Single Centre in Switzerland.

Authors:  Sofia Amylidi-Mohr; Jakub Kubias; Stefanie Neumann; Daniel Surbek; Lorenz Risch; Luigi Raio; Beatrice Mosimann
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-07-15       Impact factor: 2.915

7.  Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational Cross-Sectional Study.

Authors:  Carole A Marxer; Marlene Rauch; Clementina Lang; Alice Panchaud; Christoph R Meier; Julia Spoendlin
Journal:  Int J Environ Res Public Health       Date:  2022-06-28       Impact factor: 4.614

8.  Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland.

Authors:  Janne C Mewes; Melanie Lindenberg; Hubertus J M Vrijhoef
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

9.  Afamin: an early predictor of preeclampsia.

Authors:  Angela Köninger; Antje Enekwe; Pawel Mach; Dimitrios Andrikos; Boerge Schmidt; Mirjam Frank; Cahit Birdir; Rainer Kimmig; Alexandra Gellhaus; Hans Dieplinger
Journal:  Arch Gynecol Obstet       Date:  2018-09-15       Impact factor: 2.344

10.  Association of Ambient air Pollution with risk of preeclampsia during pregnancy: a retrospective cohort study.

Authors:  Lu Jia; Qing Liu; Huiqing Hou; Guangli Guo; Ting Zhang; Songli Fan; Li Wang
Journal:  BMC Public Health       Date:  2020-11-05       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.